The rare doctors who went beyond the clinic.
A conversation with the physicians who went further — into capital, companies, policy, and public life. Long-form conversations with the doctors building and shaping the future of medicine.
Quarterly dispatches from the host. Guest news and first listens before launch.
Thank you. You'll hear from me before anyone else.
The first aphorism every physician learns. A warning, drilled into trainees on morning rounds, against over-diagnosing the rare.
This show is about the zebras.
The physicians who did the uncommon thing — who took their training past the exam room and into the rooms where capital moves, companies build, policy forms, and the public listens. Rare, by any measure. Worth finding.
Physicians who took their training beyond the exam room — into the rooms where the future of medicine is actually built.
Hedge funds. Private equity. Venture. The MDs whose clinical judgment now shapes where the next generation of healthcare investment goes.
The physicians who built the institutions medicine runs on — care delivery platforms, diagnostic companies, digital health, biotech.
Regulators, public health leaders, and the physicians who write the laws and frameworks the rest of the field lives under.
The doctors shaping how the public understands its own health — through writing, broadcasting, and platforms larger than any single clinic.
The doctors whose work moves the field's self-understanding — the research, the books, the essays that change how medicine talks about itself.
Three rules. Every episode tests against them.
Skip the CV recitation. We've read it. We are here to find out how the guest actually thinks — the reasoning behind the decisions that shaped a career.
The show is quiet. It earns attention through substance. No political combat. No outrage bait. Real talk about real work.
"First, do no harm" is a real tension when the patient is a market, a policy, or a country. We ask how guests navigate it — without looking away.
Veeral Mehta, MD is a board-certified internal medicine physician and a Senior Associate Investor at LifeX Ventures in New York City.
Episode one lands in May 2026. Subscribe to get the first guest announcement, the launch notice, and quarterly dispatches from the host about what he's hearing in capital, companies, policy, and public life.
Thank you. You'll hear from me before anyone else.